
Accenture to Acquire Optimind
Accenture (NYSE: ACN) is to acquire Optimind, a Paris, France-based independent consulting firm.
Accenture (NYSE: ACN) is to acquire Optimind, a Paris, France-based independent consulting firm.
XXII, a Paris, France-based AI computer vision company, raised €22M in Series A funding.
Kovalee, a Paris, France-based mobile app developer, raised €8M in Series A funding.
AlgoTx, a Suresnes, France-based biotech-company developing treatment ATX01 for chemotherapy-induced peripheral neuropathy (CIPN), raised €20M in Series B funding.
Iktos, a Paris, France-based company specializing in artificial intelligence for new drug discovery, raised €15.5M in Series A funding.
N2F, a Bourg-en-Bresse, France-based provider of expense management software solutions, received €24m in Strategic Growth funding.
SESAMm, a Paris, France-based natural language processing (NLP) company serving global investment firms and corporations around the globe, raised €35M in Series B2 funding.
Inarix, a Paris, France-based provider of an AI-powered crop analysis platform, raised €3.1M in Seed funding.
Futura Gaïa, a French startup that designs and markets ready-to-use vertical farms, raised €11m in a second funding round.
MikMak, a New York-based provider of an eCommerce acceleration platform for multichannel brands, acquired Swaven, a Paris, France-based eCommerce enablement and analytics software company across EMEA, APAC, and LATAM.
Carbon Maps, a Paris, France-based climate tech startup, raised €4M in Pre-Seed funding.
Previa Medical, a Lyon, France-based startup specialized in developing predictive medical devices, raised €2.1M in Seed funding.
Brigad, a Paris, France-based provider of an app that enables self-employed professionals and businesses to connect for short-term missions, raised €33m in funding.
BiPER Therapeutics, a Strasbourg, France-based preclinical biotechnology company, raised €1.25M in Seed funding.
Ipsos, a French market research and polling company, is to acquire Xperiti, a startup specializing in Business-to-Business (B2B) research, with operations across the US, Israel and the Philippines.